Humana Available for sale investments increased by 8.9% to $17.64B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.6%, from $18.30B to $17.64B. Over 3 years (FY 2022 to FY 2025), Available for sale investments shows an upward trend with a 4.3% CAGR.
An increase reflects a larger investment portfolio size, while fluctuations in value indicate changes in market interest rates and credit spreads.
These are debt securities that are not classified as held-to-maturity or trading securities, representing investments th...
Common in insurance portfolios to balance yield generation with liquidity requirements.
other_available_for_sale_securities_debt_securities| Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.25B | $15.30B | $15.64B | $17.01B | $17.08B | $17.81B | $19.43B | $18.64B | $18.30B | $18.10B | $17.18B | $16.20B | $17.64B |
| QoQ Change | — | +7.4% | +2.2% | +8.7% | +0.4% | +4.3% | +9.1% | -4.1% | -1.8% | -1.1% | -5.1% | -5.7% | +8.9% |
| YoY Change | — | — | — | +19.3% | +11.6% | +13.9% | — | +9.6% | +7.1% | +1.6% | -11.6% | -13.1% | -3.6% |